Table 2.
Parameter | Control (n = 8) | Tumor (n = 5) | Tumor + Cas IIgly, 0.4 mg/kg per day (n = 10) | Tumor + Cas IIgly, 0.8 mg/kg per day (n = 9) |
Glucose (mg/dl) | 147.96 ± 22.35 | 186.44 ± 61.08 | 116 ± 25.35* | 111.22 ± 28.98* |
BUN | 24.40 ± 2.31 | 26.6 ± 5.24 | 25.4 ± 3.06 | 20.44 ± 2.92 |
Urea (mg/dl) | 52.22 ± 4.93 | 56.92 ± 11.2 | 54.35 ± 6.55 | 43.74 ± 6.24 |
Creatinine (mg/dl) | 0.63 ± 0.15 | 0.72 ± 0.044 | 0.63 ± 0.08 | 0.53 ± 0.07 |
Uric acid (mg/dl) | 1.65 ± 0.43 | 4.16 ± 0.78† | 2.43 ± 1.45 | 3.64 ± 0.77† |
Bilirubin (mg/dl) | 0.56 ± 0.20 | 1.1 ± 0.87 | 0.58 ± 0.21 | 0.53 ± 0.19 |
SGOT (U/l) | 206.36 ± 102.56 | 344.22 ± 148.05 | 191.67 ± 73.02 | 211.44 ± 74.49 |
SGPT (U/l) | 75.2 ± 17.2 | 67.12 ± 17.77 | 48.4 ± 13.7* | 43.77 ± 10.73‡ |
Alkaline phosphatase (U/l) | 431.22 ± 119.71 | 277.36 ± 61.81* | 318.8 ± 153.46 | 238.22 ± 96.15* |
GGT | 1.25 ± 1.03 | 5.96 ± 4.11* | 3.75 ± 2.96* | 2.5 ± 1.37 |
Total protein (g/dl) | 7.26 ± 0.17 | 6.84 ± 0.75 | 6.32 ± 0.84* | 5.13 ± 1.0† |
Albumin (g/dl) | 1.57 ± 0.20 | 2.08 ± 1.18 | 1.4 ± 0.36 | 1.5 ± 1.25 |
Globulins (mg/dl) | 5.66 ± 0.15 | 5.36 ± 0.55 | ND | 4.0 ± 0.58 |
A/G ratio | 0.25 ± 0.03 | 0.278 ± 0.075 | ND | 0.27 ± 0.044 |
Results are expressed as mean ± SEM. Statistical significance was obtained by comparing untreated rats without tumor (Control) versus untreated rats with tumor or Cas IIgly-treated rats (0.4 and 0.8 mg/kg per day) with tumor.
P ≤ .05.
P ≤ .001.
P ≤ .0001.